TGFB1 induces fetal reprogramming and enhances intestinal regeneration

Cell Stem Cell. 2023 Nov 2;30(11):1520-1537.e8. doi: 10.1016/j.stem.2023.09.015. Epub 2023 Oct 20.

Abstract

The gut epithelium has a remarkable ability to recover from damage. We employed a combination of high-throughput sequencing approaches, mouse genetics, and murine and human organoids and identified a role for TGFB signaling during intestinal regeneration following injury. At 2 days following irradiation (IR)-induced damage of intestinal crypts, a surge in TGFB1 expression is mediated by monocyte/macrophage cells at the location of damage. The depletion of macrophages or genetic disruption of TGFB signaling significantly impaired the regenerative response. Intestinal regeneration is characterized by the induction of a fetal-like transcriptional signature during repair. In organoid culture, TGFB1 treatment was necessary and sufficient to induce the fetal-like/regenerative state. Mesenchymal cells were also responsive to TGFB1 and enhanced the regenerative response. Mechanistically, pro-regenerative factors, YAP/TEAD and SOX9, are activated in the epithelium exposed to TGFB1. Finally, pre-treatment with TGFB1 enhanced the ability of primary epithelial cultures to engraft into damaged murine colon, suggesting promise for cellular therapy.

Keywords: Clu; TGFB1; fetal reversion; intestine; macrophage; monocyte; organoid transplantation; regeneration; regenerative medicine; revival stem cell.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Colon
  • Humans
  • Intestinal Mucosa* / metabolism
  • Intestines*
  • Mice
  • Organoids / metabolism
  • Signal Transduction
  • Transforming Growth Factor beta1 / metabolism
  • Transforming Growth Factor beta1 / pharmacology

Substances

  • TGFB1 protein, human
  • Transforming Growth Factor beta1
  • Tgfb1 protein, mouse